Three hundred and forty-five patients were enrolled in this randomized , double-blind , clinical trial : 120 hypertensive patients were randomized to enalapril 20 mg , 110 to lercanidipine 10 mg and 115 to enalapril/lercanidipine 20/10 mg fixed combination .